Trademark: 85495823
Status Date
Monday, October 10, 2016
Filing Date
Thursday, December 15, 2011
Published for Opposition
Tuesday, May 22, 2012
Abandoned Date
Monday, October 10, 2016
5 Human pharmaceuticals for the treatment of anti-viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic disorders, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases and respiratory diseases, muscle dystonias, wrinkles and smooth muscle disorders
Oct 11, 2016
Abandonment Notice Mailed - No Use Statement Filed
Oct 10, 2016
Abandonment - No Use Statement Filed
Feb 26, 2016
Notice Of Approval Of Extension Request E-Mailed
Feb 24, 2016
Extension 1 Granted
Feb 24, 2016
Extension 1 Filed
Feb 24, 2016
Teas Extension Received
Sep 8, 2015
Noa E-Mailed - Sou Required From Applicant
Jul 30, 2015
Ttab Release Case To Trademarks
Jul 30, 2015
Opposition Terminated No. 999999
Jul 30, 2015
Opposition Dismissed No. 999999
Nov 19, 2012
Opposition Instituted No. 999999
Jun 20, 2012
Extension Of Time To Oppose Received
May 22, 2012
Official Gazette Publication Confirmation E-Mailed
May 22, 2012
Published For Opposition
May 2, 2012
Notification Of Notice Of Publication E-Mailed
Apr 16, 2012
Law Office Publication Review Completed
Apr 16, 2012
Assigned To Lie
Mar 26, 2012
Approved For Pub - Principal Register
Mar 26, 2012
Examiner's Amendment Entered
Mar 26, 2012
Notification Of Examiners Amendment E-Mailed
Mar 26, 2012
Examiners Amendment E-Mailed
Mar 26, 2012
Examiners Amendment -Written
Mar 24, 2012
Notification Of Non-Final Action E-Mailed
Mar 24, 2012
Non-Final Action E-Mailed
Mar 24, 2012
Non-Final Action Written
Mar 24, 2012
Assigned To Examiner
Dec 22, 2011
New Application Office Supplied Data Entered In Tram
Dec 19, 2011
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
